Common questions about Сибри Бризхалер (FAQ)
Q: How quickly does Сибри Бризхалер start to work after I use it?
Official product information notes that the onset of bronchodilation is rapid, with effects often observed within 5 to 15 minutes of administration. However, this medicine is designed for long-term daily maintenance to help sustain stable breathing over time, not for immediate relief of sudden breathing problems.
Q: What if I already use other inhalers? Can I use this one too?
The official product information advises caution regarding other inhaled medicines. Guidance is specifically focused on avoiding co-administration with other anticholinergic-containing medicines due to the potential for additive effects. Information regarding other classes of inhalers (e.g., inhaled corticosteroids) is addressed by healthcare providers.
Q: Can Сибри Бризхалер affect my eyes or cause vision changes?
Yes, the official safety profile specifies a caution for patients with narrow-angle glaucoma due to the drug's mechanism. The safety profile also notes the potential for visual disturbances, such as blurred vision, as possible anticholinergic side effects.
Q: Are there studies available about its use in different populations?
Studies document the drug's use in various adult populations with Chronic Obstructive Pulmonary Disease (COPD). Official documentation indicates that dosage adjustments are typically not required for older adults or patients with mild to moderate hepatic (liver) impairment, though use is restricted in those with severe renal (kidney) impairment.
Q: Does this medicine help with coughing or only shortness of breath?
The clinical studies primarily focus on lung function and patient-reported outcomes like relief of dyspnea (shortness of breath). The official label does not specifically claim treatment for coughing as a separate indication, though cough is a common symptom of the condition treated.
Q: Why is it important to check the expiration date on the capsules?
The expiration date serves as the regulatory guarantee that the drug retains its full potency and stability until that date. Using expired medicine means that the amount of the active ingredient, glycopyrronium, cannot be guaranteed, and therefore the medicine may not function as consistently as intended.
Q: Is Сибри Бризхалер used to treat asthma?
The official indication for Сибри Бризхалер (glycopyrronium monotherapy) is the long-term maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) in adults. It is not indicated for the treatment of asthma.
Q: Can I take Сибри Бризхалер if I am taking over-the-counter cold medicine?
Many over-the-counter cold, flu, and allergy medicines contain ingredients with anticholinergic properties. Since Сибри Бризхалер is also an anticholinergic, combining it with these medicines could lead to an additive effect, resulting in an increased risk of side effects like dry mouth or urinary retention.
Q: Does this medicine interact with common blood pressure medications?
Official regulatory information does not list common blood pressure medications as specific major interactions. However, the drug's label advises caution for use in patients with certain cardiovascular conditions (e.g., unstable ischaemic heart disease) due to the drug’s potential cardiovascular effects.
Q: What types of antidepressants might interact with Сибри Бризхалер?
The official product label cautions against combining the drug with other medications that have anticholinergic properties. Certain older antidepressants, such as tricyclic antidepressants, can have significant anticholinergic effects, which could result in an increased risk of anticholinergic side effects.
Q: Can using alcohol affect the safety of this drug?
Official safety information notes potential side effects like dizziness, which may be intensified by alcohol use. The product information advises caution because side effects such as these could temporarily affect your mental alertness.
Q: Is it normal to hear a sound or taste the powder when I inhale?
Official instructions for the Breezhaler device note that a whirring sound is normal during inhalation as the capsule spins. You may also feel or taste the powder as it is delivered into the lungs, which can confirm the medicine has been delivered.
Q: Is it normal for the capsule to remain partially full after inhalation?
Yes, official procedural instructions confirm that a small amount of powder will often remain in the capsule after a successful inhalation. This is normal and does not mean the full dose was not received, assuming the whirring sound was heard.
Q: What is the best way to clean the Breezhaler device?
The official instructions state that the Breezhaler device does not require washing and should be kept dry. If cleaning is necessary, the mouthpiece may be wiped inside and outside with a clean, dry, lint-free cloth or tissue to remove residue.
Q: Can I travel with Сибри Бризхалер easily?
Official guidance requires the capsules to be kept in their original blister packaging to protect the dry powder from moisture and light. Adhering to the required storage temperature (typically room temperature) is important, and prescription medicine should generally be kept with you when traveling.
Q: Do I need to check my blood pressure while using this drug?
The official documentation advises caution for use in patients with certain heart conditions due to potential cardiovascular effects, but the patient leaflet does not instruct self-monitoring of blood pressure.
Q: Are there documented cases of drug misuse or dependency?
The active ingredient, glycopyrronium, is not classified as a controlled substance by regulatory bodies, and there is no information in the official safety warnings regarding a risk of drug misuse or dependency potential.
Q: What should I do if the inhaler device breaks?
Official instructions state that a damaged device should be discarded, as the medicine can only be delivered using a working Breezhaler device. A replacement must be obtained to ensure continued administration of the medicine.
